Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
F. Fortunato, Rachele Rossi, Maria Sofia Falzarano, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 820-820
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Misganaw Asmamaw Mengstie, Belay Zawdie Wondimu
Biologics (2021) Vol. Volume 15, pp. 353-361
Open Access | Times Cited: 285
Senescence mechanisms and targets in the heart
Maggie Chen, Richard Lee, Jessica C. Garbern
Cardiovascular Research (2021) Vol. 118, Iss. 5, pp. 1173-1187
Open Access | Times Cited: 173
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
Dianalee McKnight, Ana Morales, Kathryn E. Hatchell, et al.
JAMA Neurology (2022) Vol. 79, Iss. 12, pp. 1267-1267
Open Access | Times Cited: 61
Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing
Arezoo Mohammadian Farsani, Negin Mokhtari, Saghi Nooraei, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24606-e24606
Open Access | Times Cited: 15
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy
Kay Ohlendieck, Dieter Swandulla
Pflügers Archiv - European Journal of Physiology (2021) Vol. 473, Iss. 12, pp. 1813-1839
Open Access | Times Cited: 33
Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design
Hidetomo Yokoo, Norihito Shibata, Akinori Endo, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 15868-15882
Closed Access | Times Cited: 28
Current Concept Review: Orthopaedic Management in Duchenne Muscular Dystrophy
Uma Balachandran, Taylor Mustapich, Sheena C. Ranade
Journal of the Pediatric Orthopaedic Society of North America (2025), pp. 100154-100154
Open Access
Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice
Micky Phongsavanh, Flavien Bizot, Amel Saoudi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2583-2583
Open Access
Genetic and Clinical Landscape of Duchenne Muscular Dystrophy in Guatemala: Insights from a National Study
Marcela Orozco, Edgar Kestler, Gerardo Ramírez, et al.
Research Square (Research Square) (2025)
Open Access
Advances in Duchenne Muscular Dystrophy: Diagnostic Techniques and Dystrophin Domain Insights
Julija Sarvutiene, Arūnas Ramanavičius, Simonas Ramanavičius, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3579-3579
Open Access
miRNA dysregulation in Duchenne muscular dystrophy comorbidities
Subhashree Sivakumar, Archana Rajavel, Viswanathan Venkataraman, et al.
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
Longitudinal Follow‐Up of Patients With Duchenne Muscular Dystrophy Using Quantitative 23Na and 1H MRI
Teresa Gerhalter, Benjamin Marty, Lena V. Gast, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy
Alessandra Renzini, Nicoletta Marroncelli, Giorgia Cavioli, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 2, pp. 1339-1359
Open Access | Times Cited: 16
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
Dorota Gruber, Michele A. Lloyd-Puryear, Niki Armstrong, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 2, pp. 197-205
Open Access | Times Cited: 16
The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy
Kajetan Kiełbowski, Estera Bakinowska, Grzegorz Procyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6108-6108
Open Access | Times Cited: 3
Gene editing in common cardiovascular diseases
Anna-Maria Lauerer, Xurde M. Caravia, Lars S. Maier, et al.
Pharmacology & Therapeutics (2024), pp. 108720-108720
Open Access | Times Cited: 3
MyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro: protocols and their applications
Rachele Rossi, Silvia Torelli, Pierpaolo Ala, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 8
Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy
Michael R. Emami, Alejandro Espinoza, Courtney S. Young, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 90-102
Open Access | Times Cited: 8
Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy
A. Tejedera-Villafranca, Marisol Montolio, Javier Ramón‐Azcón, et al.
Biofabrication (2023) Vol. 15, Iss. 4, pp. 045024-045024
Open Access | Times Cited: 8
How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?
Paul Dowling, Capucine Trollet, Elisa Négroni, et al.
Proteomes (2024) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 2
Alteration of STIM1/Orai1-Mediated SOCE in Skeletal Muscle: Impact in Genetic Muscle Diseases and Beyond
Elena Conte, Paola Imbrici, Paola Mantuano, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2722-2722
Open Access | Times Cited: 15
Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
Cintia Gomez Limia, Megan Baird, M. Schwartz, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1979-1979
Open Access | Times Cited: 11
Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
Sarah Engelbeen, Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen, et al.
Nucleic Acid Therapeutics (2022) Vol. 33, Iss. 1, pp. 26-34
Open Access | Times Cited: 10
Wearable Inertial Devices in Duchenne Muscular Dystrophy: A Scoping Review
Elisa Panero, Rossella D’Alessandro, Ilaria Cavallina, et al.
Applied Sciences (2023) Vol. 13, Iss. 3, pp. 1268-1268
Open Access | Times Cited: 6
An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery
Makoto Oba, Mika Shibuya, Yuto Yamaberi, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 71, Iss. 3, pp. 250-256
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top